It is recognised that THC binds to CB1 and CB2 while CBD acts as an antagonist of GPR55, which cause inhibition of ERK- and AKT-dependent pathways to promote apoptosis and to suppress proliferation of cancer cells [16,17]. This evidence concerns the gene GPR55 and cancer.